"Liposarcoma, Myxoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A liposarcoma containing myxomatous tissue. (Dorland, 27th ed)
MeSH Number(s)
C04.557.450.550.420.425
C04.557.450.795.465.425
Concept/Terms
Liposarcoma, Myxoid- Liposarcoma, Myxoid
- Liposarcomas, Myxoid
- Myxoid Liposarcoma
- Myxoid Liposarcomas
Below are MeSH descriptors whose meaning is more general than "Liposarcoma, Myxoid".
Below are MeSH descriptors whose meaning is more specific than "Liposarcoma, Myxoid".
This graph shows the total number of publications written about "Liposarcoma, Myxoid" by people in Harvard Catalyst Profiles by year, and whether "Liposarcoma, Myxoid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 2 | 3 |
| 1995 | 1 | 2 | 3 |
| 1996 | 1 | 0 | 1 |
| 1997 | 3 | 1 | 4 |
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
| 2021 | 5 | 0 | 5 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
Below are the most recent publications written about "Liposarcoma, Myxoid" by people in Profiles.
-
Distribution and Rate of Myxoid Liposarcoma Spine Metastases: Impact on Surveillance Imaging. Ann Surg Oncol. 2023 Dec; 30(13):8647-8652.
-
The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma. Mol Cell. 2022 05 05; 82(9):1737-1750.e8.
-
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1. J Clin Oncol. 2022 04 20; 40(12):1291-1300.
-
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy. J Immunother Cancer. 2021 05; 9(5).
-
Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas. Mod Pathol. 2021 07; 34(7):1367-1372.
-
Development of machine learning model algorithm for prediction of 5-year soft tissue myxoid liposarcoma survival. J Surg Oncol. 2021 Jun; 123(7):1610-1617.
-
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial. JAMA Oncol. 2021 Jan 01; 7(1):e205865.
-
Requirement for YAP1 signaling in myxoid liposarcoma. EMBO Mol Med. 2019 05; 11(5).
-
Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases. Spine J. 2016 Mar; 16(3):291-8.
-
Histology-Guided High-Resolution Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging. Anal Chem. 2015 Dec 15; 87(24):11978-83.